Kyntra Bio (KYNB) Acquisitions (2020)
Kyntra Bio (KYNB) posted Acquisitions of $726000.0 for Q3 2020.
Kyntra Bio (KYNB) Acquisitions (2020) Analysis & Trends
Kyntra Bio has reported Acquisitions for 1 years, with the latest figure at $726000.0 in Q3 2020.
- Quarterly Acquisitions changed N/A year-over-year to $726000.0 in Q3 2020, while the trailing twelve-month figure through Sep 2023 was $726000.0 (changed N/A YoY) and the FY2023 annual result came in at $656000.0, changed N/A from the prior year.
- Acquisitions held at $726000.0 in Q3 2020 per KYNB's latest filing.
- Over five years, Acquisitions peaked at $726000.0 in Q3 2020 and troughed at $726000.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.73 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.93 Bn | 59.75 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.97 Bn | 36.87 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.22 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.98 Bn | 9.59 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | - |
| 10 | Kyntra Bio | 30.21 Mn | 30.21 Mn | 1.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 726,000.00 |